In experiments with 3D human cell cultures mimicking a number of diseases diseases, some high CBD cannabis strains demonstrated abilities to shut down coronavirus’s favorite “pathway: a receptor called ACE2.
Researchers from the University of Lethbridge put out a study in April showing 13 cannabis plants were high in CBD appeared to affect the ACE2 pathways that the virus uses to access the body “We were totally stunned at first, and then we were really happy,” one of the researchers, Olga Kovalchuk, told CTV News. CBD blocks proteins that provide a way for for COVID-19.
“Our work could have a huge influence — there aren’t many drugs that have the potential of reducing infection by 70 to 80 percent,” he told the Calgary Herald.
The study has yet to be reviewed, and it was carried out in partnership with Pathway Rx, a cannabis therapy research company, and Swysh Inc., a cannabinoid-based research company. The researchers are seeking funding to continue their efforts to support scientific initiatives to address COVID-19.
The researchers sifted through 400 cannabis strains for the study.